Teva Pharmaceutical Industries Future Growth
Future criteria checks 3/6
Teva Pharmaceutical Industries is forecast to grow earnings and revenue by 64.8% and 1.5% per annum respectively while EPS is expected to grow by 75.6% per annum.
Key information
64.8%
Earnings growth rate
75.6%
EPS growth rate
Pharmaceuticals earnings growth | 14.2% |
Revenue growth rate | 1.5% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 28 Nov 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 15,899 | 1,034 | 2,072 | 1,480 | 9 |
12/31/2024 | 15,531 | 824 | 2,416 | 1,635 | 10 |
12/31/2023 | 15,355 | 179 | 2,395 | 2,068 | 11 |
9/30/2023 | 15,273 | -2,209 | 608 | 1,157 | N/A |
6/30/2023 | 15,017 | -2,234 | 1,173 | 1,695 | N/A |
3/31/2023 | 14,925 | -1,603 | 964 | 1,494 | N/A |
12/31/2022 | 14,925 | -2,353 | 1,042 | 1,590 | N/A |
9/30/2022 | 15,141 | -1,291 | 514 | 1,073 | N/A |
6/30/2022 | 15,433 | -1,054 | 476 | 1,059 | N/A |
3/31/2022 | 15,557 | -615 | 585 | 1,154 | N/A |
12/31/2021 | 15,878 | 417 | 236 | 798 | N/A |
9/30/2021 | 16,231 | 726 | 88 | 673 | N/A |
6/30/2021 | 16,324 | -3,915 | -131 | 451 | N/A |
3/31/2021 | 16,284 | -3,982 | -94 | 506 | N/A |
12/31/2020 | 16,659 | -3,990 | 638 | 1,216 | N/A |
9/30/2020 | 16,673 | -4,031 | 902 | 1,423 | N/A |
6/30/2020 | 16,788 | 4 | 894 | 1,441 | N/A |
3/31/2020 | 17,095 | -825 | 413 | 941 | N/A |
12/31/2019 | 16,887 | -999 | 223 | 748 | N/A |
9/30/2019 | 16,396 | -4,048 | -42 | 577 | N/A |
6/30/2019 | 16,831 | -4,007 | 84 | 673 | N/A |
3/31/2019 | 17,355 | -3,559 | 449 | 1,062 | N/A |
12/31/2018 | 18,271 | -2,399 | 1,795 | 2,446 | N/A |
9/30/2018 | 19,693 | -11,059 | 2,233 | 2,938 | N/A |
6/30/2018 | 20,781 | -10,256 | 2,534 | 3,312 | N/A |
3/31/2018 | 21,800 | -16,050 | 2,750 | 3,585 | N/A |
12/31/2017 | 21,853 | -16,525 | 1,351 | 2,225 | N/A |
9/30/2017 | 23,479 | -5,963 | 1,851 | 2,791 | N/A |
6/30/2017 | 23,425 | -6,145 | N/A | 3,457 | N/A |
3/31/2017 | 22,743 | 78 | N/A | 3,985 | N/A |
12/31/2016 | 21,903 | 68 | N/A | 3,890 | N/A |
9/30/2016 | 20,292 | 1,591 | N/A | 5,415 | N/A |
6/30/2016 | 19,552 | 1,346 | N/A | 5,047 | N/A |
3/31/2016 | 19,480 | 1,697 | N/A | 5,564 | N/A |
12/31/2015 | 19,652 | 1,573 | N/A | 5,542 | N/A |
9/30/2015 | 19,939 | 1,775 | N/A | 5,679 | N/A |
6/30/2015 | 20,174 | 2,548 | N/A | 6,010 | N/A |
3/31/2015 | 20,253 | 2,757 | N/A | 5,583 | N/A |
12/31/2014 | 20,272 | 3,055 | N/A | 5,127 | N/A |
9/30/2014 | 20,534 | 2,748 | N/A | 4,191 | N/A |
6/30/2014 | 20,535 | 2,583 | N/A | 3,211 | N/A |
3/31/2014 | 20,414 | 1,383 | N/A | 3,033 | N/A |
12/31/2013 | 20,314 | 1,269 | N/A | 3,237 | N/A |
9/30/2013 | 20,133 | 1,209 | N/A | 3,998 | N/A |
6/30/2013 | 20,046 | 419 | N/A | 4,602 | N/A |
3/31/2013 | 20,116 | 1,734 | N/A | 4,918 | N/A |
12/31/2012 | 20,317 | 1,963 | N/A | 4,572 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TEV is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).
Earnings vs Market: TEV is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: TEV is expected to become profitable in the next 3 years.
Revenue vs Market: TEV's revenue (1.5% per year) is forecast to grow slower than the BG market (26.5% per year).
High Growth Revenue: TEV's revenue (1.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if TEV's Return on Equity is forecast to be high in 3 years time